Zarling et al. have described two phosphopeptides, one from insulin receptor substrate 2 and another from cell division cycle 25b (CDC25B) as CD8+ T-cell epitopes that are presented by multiple HLA-A2+ cancers [98]. Here, CD8A is linked to cancer.